Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma.

Pilskog, Martin; Beisland, Christian; Akslen, Lars A; Bostad, Leif; Haug, Åse; Heinrich, Daniel; Hjelle, Karin M; Straume, Oddbjørn

Pilskog, Martin; Beisland, Christian; Akslen, Lars A; Bostad, Leif; Haug, Åse; Heinrich, Daniel; Hjelle, Karin M; Straume, Oddbjørn.

Affiliation

Pilskog M; Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.
Beisland C; Department of Oncology, Haukeland University Hospital, 5021, Bergen, Norway.
Akslen LA; Department of Urology, Haukeland University Hospital, 5021, Bergen, Norway.
Bostad L; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Haug Å; Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.
Heinrich D; Department of Pathology, Haukeland University Hospital, 5021, Bergen, Norway.
Hjelle KM; Department of Pathology, Haukeland University Hospital, 5021, Bergen, Norway.
Straume O; Department of Oncology, Haukeland University Hospital, 5021, Bergen, Norway.

BMC Urol ; 17(1): 74, 2017 Aug 31.

Article de En | MEDLINE | ID: mdl-28859644

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyrroles / Protéine C-réactive / Néphrocarcinome / Marqueurs biologiques tumoraux / Indoles / Tumeurs du rein / Antinéoplasiques Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: BMC Urol Sujet du journal: UROLOGIA Année: 2017 Type de document: Article Pays d'affiliation: Norvège Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google